Antiretroviral News and Research

RSS

FDA ADAC recommends approval of Quad for HIV-1 infection

Gilead Sciences, Inc. today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 13 to 1 in support of approval of the Quad, a complete single tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, for the treatment of HIV-1 infection in treatment-naïve adults.

14 May 2012

Mylan introduces Atorvastatin Calcium in France, Belgium, UK, Ireland and the Netherlands

Mylan Inc. today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland.

11 May 2012

This Mother's Day, ensure babies everywhere are born free of HIV

Ahead of Mother's Day on May 13, UNAIDS Executive Director Michel Sidibe writes in this post in the Huffington Post's "Global Motherhood" blog, "Together we can go from 390,000 children becoming infected with HIV each year to zero," and he highlights "three simple things we can all do to ensure babies everywhere can be born free from HIV."

11 May 2012

MSF says additional resources needed to improve ART access in Burma

Medecins Sans Frontieres (MSF), the largest provider of antiretroviral treatment (ART) in Burma, also known as Myanmar, are calling for the gap between the need for and access to ART in the country to be closed, the Guardian reports.

11 May 2012

FDA ADAC recommends approval of Gilead’s Truvada for HIV

Gilead Sciences, Inc. today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted to support approval of once-daily oral Truvada(emtricitabine and tenofovir disoproxil fumarate) to reduce the risk of HIV-1 infection among uninfected adults, an HIV prevention strategy called pre-exposure prophylaxis or PrEP.

11 May 2012

USAID launches five-year initiative in Nigeria to strengthen HIV, TB services

U.S. Ambassador to Nigeria Terence McCulley on Tuesday in Abuja, Nigeria, launched a five-year, $224 million USAID program, titled Strengthening Integrated Delivery of HIV/AIDS Services (SIDHAS), that aims to "increase access to high-quality comprehensive HIV/AIDS and tuberculosis prevention, treatment, care and related services through improved efficiencies in service delivery," the Daily Trust reports.

10 May 2012

Option for couples to test together, access ART for prevention can reduce HIV risk

"If we don't leverage the power of innovation to transform how health services are provided and utilized, efforts to stop new HIV infections and AIDS-related deaths can reach a stalemate," UNAIDS Executive Director Michel Sidibe writes in this opinion piece in the Huffington Post's "Healthy Living" blog.

9 May 2012

PEPFAR releases 8th annual report to Congress

The Center for Global Health Policy's "Science Speaks" blog notes that PEPFAR recently released its 8th annual report to Congress.

8 May 2012

Breckenridge finalizes agreement with Huahai to market Nevirapine Tablets

Breckenridge Pharmaceutical, Inc. announced today that it has finalized its agreement with Zhejiang Huahai Pharmaceuticals Co., Ltd. (Huahai) to market Nevirapine Tablets. Nevirapine 200mg Tablets are AB rated to Viramune a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS, which is marketed by Boehringer Ingelheim.

5 May 2012

Global Fund completes reorganization of workforce, tightens focus to 20 'high-impact countries'

The Global Fund to Fight AIDS, Tuberculosis and Malaria "is cutting its workforce and tightening its focus on 20 countries hardest hit by AIDS, tuberculosis and malaria," Reuters reports. Gabriel Jaramillo, who took over as general manager of the fund in January, "said in a statement that the fund had completed a reorganization that would rebalance its workforce with 39 percent more people managing grants and 38 percent fewer in support roles," the news service notes.

3 May 2012

African-Americans with HIV less likely to adhere to ART therapy

African-Americans with HIV are much less likely to adhere to drug therapy than others with the disease, according to a University of Michigan study.

3 May 2012

World behind on pledge to reduce HIV/AIDS infections, improve treatment, U.N. report says

"The world is falling behind in its pledge to reduce HIV/AIDS infections and improve treatment, especially in sub-Saharan Africa, according to a U.N. report released Monday" by U.N. Secretary-General Ban Ki-moon, the Associated Press reports.

2 May 2012

Airborne drones could provide innovative method of delivering food, medicines

In a Foreign Policy opinion piece, former U.S. Ambassador Jack Chow, who served as a special representative for HIV/AIDS under former Secretary of State Colin Powell and currently is a professor at Carnegie Mellon's Heinz College of Public Policy, examines the challenges of delivering humanitarian aid and how "[t]he technological versatility of airborne drones, the flying robots that are already transforming warfare, ... has the potential to revolutionize how humanitarian aid is delivered worldwide."

30 Apr 2012

Blog continues coverage of International Treatment as Prevention conference in Vancouver

The Center for Global Health Policy's "Science Speaks" blog continued its coverage of the 2nd International Treatment as Prevention Workshop in Vancouver.

27 Apr 2012

Blog posts report on International Treatment as Prevention conference in Vancouver

Two separate posts in the Center for Global Health Policy's "Science Speaks" blog report on the International Treatment as Prevention conference in Vancouver. The first post recaps an update from Stephen Becker of the Bill & Melinda Gates Foundation on Tuesday "about the Foundation's treatment optimization activities," writing, "According to Becker, the Foundation acknowledges that treatment will be at the center of HIV prevention efforts, but 'no amount of treatment will obviate the need for primary prevention modalities.'"

27 Apr 2012

Poverty linked to HIV infection among heterosexuals living in inner-city neighborhoods

In a groundbreaking study published last year, scientists reported that effective treatment with HIV medications not only restores health and prolongs life in many HIV-infected patients, but also curtails transmission to sexual partners up to ninety-seven percent. However, a new study by UCSF scientists shows that lack of basic living needs severely undercuts these advances in impoverished men.

27 Apr 2012

International Microbicides Conference 2012 concludes

The conclusion of the 2012 International Microbicides Conference, a gathering of researchers, advocates and funders in the HIV prevention field, wrapped up three days of discussion focused on access to prevention technologies, adherence in clinical trials, innovative financing, dual prevention technologies and new methods of preventing rectal transmission of HIV.

26 Apr 2012

Daily ART safe and effective in preventing mother-to-child HIV transmission

In early results of a large-scale randomized study published in 2010 and led by researchers from the University of North Carolina at Chapel Hill, giving daily antiretroviral drugs (ART) to HIV-infected moms or their breastfeeding babies for 28 weeks proved safe and effective for preventing mother-to-child HIV transmission through breast milk.

26 Apr 2012

UNAIDS welcomes new WHO guidelines for HIV testing, counseling, ART for couples

UNAIDS on Thursday "called on all countries to implement new WHO guidelines that encourage couples to go together for HIV testing to ascertain their status" and recommend offering antiretroviral therapy (ART) to people living with HIV who have a partner without HIV, "even when they do not require it for their own health," the U.N. News Centre reports.

21 Apr 2012

WHO releases guidance on couples testing, counseling, including ART for discordant couples

The WHO on Wednesday released its new 54-page "Guidance on couples HIV testing and counselling, including antiretroviral therapy (ART) for treatment and prevention in serodiscordant couples: Recommendations for a public health approach," according to the Center for Global Health Policy's "Science Speaks" blog.

20 Apr 2012

Antiretroviral News and Research

FDA ADAC recommends approval of Quad for HIV-1 infection

Mylan introduces Atorvastatin Calcium in France, Belgium, UK, Ireland and the Netherlands

This Mother's Day, ensure babies everywhere are born free of HIV

MSF says additional resources needed to improve ART access in Burma

FDA ADAC recommends approval of Gilead’s Truvada for HIV

USAID launches five-year initiative in Nigeria to strengthen HIV, TB services

Option for couples to test together, access ART for prevention can reduce HIV risk

PEPFAR releases 8th annual report to Congress

Breckenridge finalizes agreement with Huahai to market Nevirapine Tablets

Global Fund completes reorganization of workforce, tightens focus to 20 'high-impact countries'

African-Americans with HIV less likely to adhere to ART therapy

World behind on pledge to reduce HIV/AIDS infections, improve treatment, U.N. report says

Airborne drones could provide innovative method of delivering food, medicines

Blog continues coverage of International Treatment as Prevention conference in Vancouver

Blog posts report on International Treatment as Prevention conference in Vancouver

Poverty linked to HIV infection among heterosexuals living in inner-city neighborhoods

International Microbicides Conference 2012 concludes

Daily ART safe and effective in preventing mother-to-child HIV transmission

UNAIDS welcomes new WHO guidelines for HIV testing, counseling, ART for couples

WHO releases guidance on couples testing, counseling, including ART for discordant couples

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News